You can try blaming Friday the 13th for today’s misery on Wall Street, but that wouldn’t be doing justice to the damage Monday and Tuesday also unleashed. So, despite some healthy rebounding on Wednesday and Thursday, the equity indices all suffered a losing week — the second in a row, and the worst weekly performance... More
CZR
Recent Articles
Amylin Perks Up on Rejection — Wednesday’s IP Market Recap
A spurned bid from Bristol-Myers Squibb sends AMLN up 54% on speculation that other offers will roll in. More
Don’t Put Your Chips on This Casino!
With nearly $20 billion in debt, the only thing that can save this company is legalized online poker. Warning: Don't hold your breath. More
4 ‘Sustainable’ Gaming Stocks
With casino stocks especially, the only sure thing is that luck can change fast. But here are some best bets. More
This Week’s IPOs: Biotechs and a Cloud Play
Companies that develop biofuel feedstocks, cancer treatments, and a cloud-based video-management platform are coming to market. More
Groupon Deals a Dud — Wednesday’s IP Market Recap
A poor first earnings report is taking an after-hours toll on GRPN shares. More
